Type 1 Diabetes

The AJMC® Type 1 Diabetes compendium is a comprehensive resource for news and interviews about this chronic autoimmune condition.

Latest News

counting calories | Image Credit: Andrii Symonenko-stock.adobe.com
T1D Management: Carbohydrate Counting With Technology

June 27th 2024

A new study highlights the potential of technology to aid in type 1 diabetes (T1D) management by balancing minimal user input with significant data output to improve user engagement and time in range.

older person with T1D | Image Credit: dorde-stock.adobe.com
More People With T1D Are Living Into Old Age

June 19th 2024

blood sugar control concept | Image Credit: Phruetthiphong-stock.adobe.com
AYA With T1D Have Suboptimal Glucose Control

June 16th 2024

T1D icon | Image Credit: MQ-Illustrations-stock.adobe.com
Gender May Affect Whether, Why Patients With T1D Exercise

June 12th 2024

Social media | Image Credit: Production Perig-stock.adobe.com
Patients With T1D and HCPs Talk Social Media and Self-Management

June 7th 2024

Understanding Autoimmunity in Type 1 Diabetes and Potential for Therapeutic Opportunities

This piece explores the history; physical, economic, and psychosocial burden; and clinical pathophysiology of type 1 diabetes to evaluate opportunities for earlier intervention to change the standard of care for this disease and improve overall outcomes.

image of Understanding Autoimmunity in Type 1 Diabetes and Potential for Therapeutic Opportunities

More News

Review Links Risk Factors in Type 1 Diabetes to Cognitive Impairment
September 2nd 2022

Review Links Risk Factors in Type 1 Diabetes to Cognitive Impairment

Julia Bonavitacola
A narrative review found that some risk factors may be associated with cognitive impairment in patients with type 1 diabetes.
food on table
September 1st 2022

Effects of Advanced Hybrid Closed Loop System on Glucose Control in People Fasting During Ramadan

Hayden E. Klein
People with type 1 diabetes (T1D) who partake in fasting during Ramadan may benefit from using an advanced hybrid closed loop (AHCL) insulin pump system.
Viral Shah, MD
August 27th 2022

Dr Viral Shah Emphasizes Importance of Patient Education on T1D Technologies

AJMC Staff
The next step for health care professionals is to teach patients how to act on the data collected by intermittently scanned glucose sensing technologies, according to Viral Shah, MD, an endocrinologist and scientist.
image of a scale
August 23rd 2022

The Impact of Childhood Obesity on Adult T1D, Other Autoimmune Conditions

Lindsey Mulrooney
A recent review examined to what extent childhood obesity increases the risk of various autoimmune diseases in adulthood, including type 1 diabetes (T1D), and the benefits that accrue if weight reduction begins in early life.
mother, child, and doctor looking at red clipboard
August 20th 2022

Potential Link Found Between 3 Biomarkers, DKD Risk in Pediatric T1D

Hayden E. Klein
A study found cystatin C, renal resistance index, and urinary kidney injury molecule-1 were significantly associated with risk of diabetic kidney disease (DKD) in children and adolescents with type 1 diabetes (T1D).
Beta Cell Reactivation May Be Viable Treatment for Patients With Type 1 Diabetes
August 17th 2022

Beta Cell Reactivation May Be Viable Treatment for Patients With Type 1 Diabetes

Lindsey Mulrooney
Researchers achieved successful reactivation of pancreatic stem cells to become insulin expressing, suggesting future potential for replacing destroyed beta cells in patients with type 1 diabetes with newborn insulin-generating cells.
Viral Shah, MD
August 12th 2022

Dr Viral Shah Addresses Gap in T1D Technology Uptake

AJMC Staff
More efforts need to be made to remove unconscious bias when implementing approved diabetes technologies into clinical practice for all patients, said Viral Shah, MD, an endocrinologist and scientist.
glucose monitor
August 10th 2022

England's NHS Rolls Out Prescription CGMs for Patients With T1D

Hayden E. Klein
The National Health Service (NHS) in England has made the Dexcom ONE real-time Continuous Glucose Monitoring System available by prescription to patients with type 1 diabetes (T1D).
Closed-Loop Insulin Delivery Has Glycemic Benefits During Sleep, but Sleep Quality Deteriorates
August 4th 2022

Closed-Loop Insulin Delivery Has Glycemic Benefits During Sleep, but Sleep Quality Deteriorates

Lindsey Mulrooney
Compared with sensor-augmented pump therapy, closed-loop insulin delivery increased glucose time in range and reduced hypoglycemia episodes but detracted from sleep quality.
Viral Shah, MD
August 2nd 2022

Dr Viral Shah Emphasizes Payer's Role in Patient Access to T1D Treatments

AJMC Staff
While therapies for type 1 diabetes (T1D) are becoming more advanced, the problem is patients can't access them, said Viral Shah, MD, an endocrinologist and scientist.
Viral Shah, MD
July 29th 2022

Diabetes, Osteoporosis Research Is a "Hot Topic," Says Dr Viral Shah

AJMC Staff
Viral Shah, MD, an endocrinologist and scientist, discusses ongoing research on preventing bone fractures in people with type 1 diabetes (T1D).
a woman using a CGM
July 27th 2022

Use of Continuous Glucose Monitoring Devices Varies by Age for Patients With T1D

Lindsey Mulrooney
Probability of continuous glucose monitoring device use was highest for patients with type 1 diabetes (T1D) in middle adulthood, decreasing as older age increased.
Viral Shah, MD
July 23rd 2022

Dr Viral Shah Explains His Research on Bone Fracture Predictors in T1D

AJMC Staff
Viral Shah, MD, an endocrinologist and scientist, discusses his research on fracture risk assessment without bone mineral density as a predictor of major fractures in patients with type 1 diabetes (T1D).
picture of child's hand with crayons
July 21st 2022

Screenings for Autoimmune Diseases Necessary for Children, Adolescents With T1D

Lindsey Mulrooney
Current guidelines recommend screening for the 2 most commonly diagnosed autoimmune diseases among adolescent patients with type 1 diabetes, but researchers suggest that additional screenings could benefit patients.
group of children
July 15th 2022

Islet Autoantibody Tests at 2 Ages Predict Pediatric T1D

Hayden E. Klein
Screening for islet autoantibodies at ages 2 and 6 was highly predictive of type 1 diabetes (T1D) onset by age 15.
Stacey Simon, PhD
July 12th 2022

Dr Stacey Simon Gives Advice for High-Quality Sleep Among Children With T1D

Hayden E. Klein
Patients, parents, and diabetes health care providers all play a role in ensuring children with type 1 diabetes (T1D) get adequate sleep, said Stacey Simon, PhD, sleep psychologist and associate professor, University of Colorado Denver, Children's Hospital Colorado.
Image of the word diabetes
July 7th 2022

Targeting β Cells May Hold Promise for Preventing and Treating T1D

Rose McNulty
Although the autoimmune response that reduces β cell numbers has often been the focus of research in type 1 diabetes (T1D), findings from a new study suggest proinflammatory signaling in islet β cells may play a significant role in disease progression.
Dr Viral Shah on Uncovering Findings About T1D, Bone Fracture Risk, and Osteoporosis
June 30th 2022

Dr Viral Shah on Uncovering Findings About T1D, Bone Fracture Risk, and Osteoporosis

AJMC Staff
Viral Shah, MD, an endocrinologist and scientist, discusses the growing field of research into the connections between type 1 diabetes (T1D) and osteoporosis.
Image of a sad teenager
June 30th 2022

T1D Risk-Taking Survey Reliable, Valid for Use Among Adolescents

Rose McNulty
The Diabetes-Specific Risk-Taking Inventory proved useful in assessing risk-taking behavior in adolescents with type 1 diabetes (T1D), but future research on potential interventions is needed.
Image of words diabetes and genetics interconnected as puzzle pieces
June 23rd 2022

New Evidence, Mindset Could Help Better Diagnose Adult-Onset T1D

Jared Kaltwasser
Research supports markers like C-peptide not only for the diagnosis of type 1 diabetes (T1D), but also for patient management.
Disparities Persist in Insulin Pump Uptake in Youth With T1D
June 16th 2022

Disparities Persist in Insulin Pump Uptake in Youth With T1D

Lindsey Mulrooney
Despite the increased prevalence of insulin pump use over the past 2 decades, there have been few improvements in uptake of the devices among patients who are Black or who come from lower socioeconomic levels.
healthy food
June 10th 2022

Study Examines T1D Eating Patterns of Youth After COVID-19 Lockdowns in Italy

Rose McNulty
Findings of a study on children and adolescents with type 1 diabetes (T1D) in Italy suggest lockdown periods during COVID-19 did not increase disordered eating symptoms or adversely affect disease management.
teens
June 4th 2022

Social Support, Access to Care Key Issues for Young Adults With T1D

Jared Kaltwasser
Patients said they benefited from diabetes management technology, but also from social accountability.
pregnant woman
June 1st 2022

Carbohydrate Intake Key to Glycemic Control in Pregnant Women With T1D, Data Show

Jared Kaltwasser
Body mass index did not appear to correlate with glycemic control, the study found.
kidneys
May 28th 2022

Study Highlights Risk Factors for Renal Disease in Patients With T1D

Jared Kaltwasser
The study suggests blood pressure and cholesterol medications may be appropriate for some younger patients in order to prevent renal complications.
man holding stomach
May 25th 2022

Study: Gut Microbiota of People With T1D Varies Significantly From Healthy Controls

Jared Kaltwasser
The findings could lead to new insights into how type 1 diabetes develops.
Image of doctor and patient
May 20th 2022

All-Cause Mortality Falling Among People With Type 1 Diabetes

Jared Kaltwasser
In some cases, however, the rate of decline is no different than that of the general population, according to new research.
older woman
May 16th 2022

Insulin Pumps, CGM Help Empower Older Adults With Type 1 Diabetes to Exercise

Jared Kaltwasser
All patients said insulin pump therapy helped their diabetes management related to exercise.
Site Logo
May 14th 2022

Researchers Call for Push to More Holistic, Collaborative Care for Young Adults With T1D

Jaime Rosenberg
The group noted that this transformation should affect changes at every level, including at the individual level during patient visits, at the organization level in how clinical encounters are organized, and at the national level in both policies and guidelines for type 1 diabetes (T1D).
Study Examines Impact of Higher C-Peptide Levels on T1D
May 13th 2022

Study Examines Impact of Higher C-Peptide Levels on T1D

Jaime Rosenberg
The new findings come from a 15-year study examining the natural course of C-peptide in children and adolescents with type 1 diabetes (T1D).
<123456789>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo